Abeona Therapeutics (ABEO) Other financing activities (2012 - 2024)
Abeona Therapeutics (ABEO) recorded quarterly Other financing activities of $963000.0 in Q1 2024, up 132.89% quarter-over-quarter from -$2.9 million in Q4 2015.
Abeona Therapeutics (ABEO) Other financing activities (2012 - 2024) Analysis & Trends
Abeona Therapeutics' Other financing activities history runs 5 years deep, the most recent figure standing at $963000.0 for Q1 2024.
- In Q1 2024, Other financing activities changed N/A year-over-year to $963000.0; the TTM figure through Dec 2024 stood at $963000.0 (changed N/A YoY), while the FY2024 annual figure was $963000.0, up 542.0% from the prior year.
- Other financing activities was $963000.0 for Q1 2024 at Abeona Therapeutics, up from -$2.9 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $963000.0 in Q1 2024 to a low of $963000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Abeona Therapeutics | 325.29 Mn | 157.02 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 963,000.00 |
| Mar 31, 2024 | 963,000.00 |
| Dec 31, 2015 | -2.93 Mn |
| Dec 31, 2015 | -2.93 Mn |
| Sep 30, 2015 | 1.89 Mn |
| Sep 30, 2015 | 1.89 Mn |
| Mar 31, 2015 | 32,000.00 |
| Mar 31, 2015 | 32,000.00 |
| Sep 30, 2014 | 84,000.00 |
| Sep 30, 2014 | 84,000.00 |
| Mar 31, 2014 | 75,000.00 |
| Mar 31, 2014 | 75,000.00 |
| Dec 31, 2013 | -41,000.00 |
| Dec 31, 2013 | -41,000.00 |
| Sep 30, 2013 | 45,000.00 |
| Sep 30, 2013 | 45,000.00 |
| Jun 30, 2013 | 123,000.00 |
| Jun 30, 2013 | 123,000.00 |
| Mar 31, 2013 | 29,000.00 |
| Mar 31, 2013 | 29,000.00 |